Japan's HIV test market to reach US$58m in ten years
High-tech healthcare in Japan poses potential for improvement in HIV treatment and prevention.
With advances in testing technologies and an increasing number of tests, the HIV tests market in Japan is seen to reach US$58m in 2033, said GlobalData.
In its report, GlobalData said Japan’s HIV tests market accounts for around 20% of the Asia-Pacific market in 2023.
Jyoti Sharma, Medical Devices Analyst at GlobalData, said, "In some instances, HIV remains undetectable due to an exceptionally low viral load; however, an undetectable viral load does not signify the absence of HIV."
"Instead, it indicates that the virus falls below the threshold of detection in standard tests, highlighting the need for innovative approaches in HIV management," added Sharma.
Sharma also said the "healthcare sector in Japan is experiencing a profound change, propelled by innovative technologies and strategic collaborations."
"With its commitment to innovation, along with its modern health infrastructure, Japan has the potential for considerable improvement in the treatment and prevention of viruses like HIV, setting new benchmarks for healthcare excellence in the years to come," read the statement.